What are INDmoney investors doing with Unjha Formulations shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
+15%
Searches for Unjha Formulations on INDmoney have increased by 15% over the last 30 days.
Unjha Formulations Stock Performance
as on September 16, 2026 at 9:31 pm IST
Day's High
₹32.00₹33.294.03%
Upside

52 Week's Low
52 Week's High
₹17.52₹36.38
45.25%
Downside
13.69%
Upside

Unjha Formulations share price movements today
- Previous Close
- ₹33.30
- Open
- ₹33.29
- Volume
- 5,138.00
- Upper Circuit
- ₹34.96
- Lower Circuit
- ₹31.64
- Day's Low - High
- ₹32.00 - ₹33.29
- 52 Week Low - High
- ₹17.52 - ₹36.38
Unjha Formulations Historical Returns
- 1 Month Return
- + 21.09 %
- 3 Month Return
- + 69.04 %
- 1 Year Return
- + 33.84 %
- 3 Year Return
- + 137.86 %
- 5 Year Return
- + 255.01 %
Unjha Formulations Fundamentals
as on September 16, 2026 at 4:01 pm IST
Market Cap
₹14.92 Cr
Return on Equity (ROE)
14.97
PE Ratio (TTM)
32.08
Return on capital employed (ROCE)
20.53
Industry PE ratio
51.81
Beta (LTM)
0.48
P/B Ratio
2.36
Dividend Yield
0PEG Ratio
38.19
Quarterly Earnings Growth YOY
-58.97
EPS (TTM)
0Book Value
0Unjha Formulations Stock Valuation
as on September 16, 2026 at 4:01 pm IST
Unjha Formulations in the last 5 years
Lowest (-168.43x)
October 11, 2021
Today (32.08x)
September 11, 2026
Industry (51.81x)
September 11, 2026
Highest (137.38x)
July 16, 2025
Today’s Price to Earnings Ratio: 32.08x
Unjha Formulations Technical Analysis
Track how Unjha Formulations technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | -0.24 | |
CCI (20) | -60.61 | Neutral |
RSI (14) | 0 | Bullish |
Momentum (10) | 0 | Neutral |
ADI (14) | 56.09 | |
Ultimate Oscillator (7,14,28) | 0 |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 32.36 | |
EMA (20) | 32.27 | |
VWMA (20) | 32.15 | |
SMA (50) | 32.68 | |
EMA (50) | 32.56 | |
SMA (200) | 32.99 | |
EMA (200) | 32.93 | |
KAMA (200) | 32 | |
DEMA (200) | 32.63 |
Unjha Formulations Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Unjha Formulations with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 14.92 | 51% | 0.00 | NA | 15 | |
| NA | 29.19 | 47.69% | 0.00 | 1 | NA | |
| BUY | 15,409.97 | 11.25% | 0.50 | 259 | 1,054 | |
| NA | 11.79 | 21.54% | 0.00 | -1 | 21 | |
| HOLD | 14,671.79 | -3.06% | 0.54 | 1,371 | 4,078 |
Unjha Formulations Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Unjha Formulations Ltd Annual Profit & Loss
Figures in Rupees Crores
Unjha Formulations Ltd Cash Flow
Figures in Rupees Crores
Unjha Formulations Corporate Actions
View detailed summary of the earnings and dividend history of Unjha Formulations.
Unjha Formulations Ltd Earnings Results
Unjha Formulations Ltd’s net profit fell -58.97% since last year same period to ₹0.16Cr in the Q1 2026-2027. On a quarterly growth basis, Unjha Formulations Ltd has generated 121.62% jump in its net profits since last 3-months.
Read More about Earnings Results
Insights on Unjha Formulations Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise

In the last 1 month, Unjha Formul. stock has moved up by 21.1%
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 36.93% of holdings in Jun 2026 quarter
NO EFFECTAgainst Peers

In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 17.0%
NO EFFECTAgainst Peers

In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.4% return, outperforming this stock by 19.5%
NO EFFECTRetail Holding Unchanged

Retail Investor holdings remained unchanged at 63.08% of holdings in Jun 2026 quarter
About Unjha Formulations Ltd
Revenue: ₹3.31Cr as on June 2026 (Q1 FY27)
Net Profit: ₹0.16Cr as on June 2026 (Q1 FY27)
Chairperson Name: Jashodaben S Patel
| Organisation | Unjha Formulations Ltd |
| Headquarters | Patan |
| Industry | Pharmaceuticals |
| CEO | Jashodaben S Patel |
| E-voting on shares | Click here to vote |
FAQs
What is Unjha Formulations share price today?
Unjha Formulations share price today stands at ₹32 as on at the close of the market. Unjha Formulations share today touched a day high of ₹33.29 and a low of ₹32.
What is the 52 week high and 52 week low range for Unjha Formulations share?
Unjha Formulations touched a 52 week high of ₹36.38 and a 52 week low of ₹17.52. Unjha Formulations share price today i.e. is closed at ₹32, which is -12.04% down from its 52 week high and 82.65% up from its 52 week low.
What is Unjha Formulations's market capitalisation today?
Unjha Formulations market capitalisation is ₹14.92 Cr as on .
How to buy Unjha Formulations shares?
To buy Unjha Formulations shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 531762 or Unjha Formulations Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Unjha Formulations shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Unjha Formulations trading volume today?
Unjha Formulations trading volume is 5,138.00 as on . This means that 5,138.00 shares of Unjha Formulations were bought and sold on the stock market during today's trading session.